Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2018; 22(02): 190-194
DOI: 10.1055/s-0037-1604064
Update Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact

Sertaç Yetişer
1   Department of Otorhinolaryngology, Anadolu Saglik Merkezi, Gebze, Kocaeli, Turkey
› Author Affiliations
Further Information

Publication History

30 March 2017

20 May 2017

Publication Date:
17 July 2017 (online)

Also available at
   Permissions and Reprints

Abstract

Introduction Intratympanic gentamicin regulates the symptoms in most patients with incapacitating Ménière's disease. The treatment protocols have changed over the years from medical labyrinthectomy to preservation of vestibular function.

Objectives This study aims to review the audiovestibular response related to the effect of the drug in controlling vertigo.

Data Synthesis Articles were identified by means of a search in the PubMed database using the key words Meniere and intratympanic or transtympanic gentamicin. Total 144 articles were reviewed after excluding those that were technical reports, those based on experimental animal studies, those that focused on outcomes other than vertigo (tinnitus or aural fullness), those with delivery methods other than tympanic membrane injection, and those with bilateral cases. If there was more than one article by the same author(s) or institution, only the most recent one matching the aforementioned criteria and those that were not overlapping were included.

Conclusion Titration methods or multiple injections on a daily basis can be preferred if the patients have profound or non-serviceable hearing, since these methods have significant incidence of hearing loss. Treatment protocols with a frequency of injection not shorter than once a week, or those with injections on a monthly basis as “needed” provide the same level of vertigo control with better preservation of hearing. Caloric testing is not an ideal tool to analyze the correlation between vertigo control and the effect of gentamicin as compared with gain asymmetry of the vestibulo-ocular reflex. Vestibular-evoked myogenic potentials and the head thrust test are more reliable than other vestibular tests for the follow-up of patients undergoing gentamicin treatment.

Keywords

Ménière's disease - intratympanic gentamicin - vertigo
 

  • References

  • 1 Lange G. [The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1977; 56 (05) 409-414
    Google Scholar
  • 2 Möller C, Odkvist LM, Thell J, Larsby B, Hydén D. Vestibular and audiologic functions in gentamicin-treated Menière's disease. Am J Otol 1988; 9 (05) 383-391
    Google Scholar
  • 3 Laitakari K. Intratympanic gentamycin in severe Ménière's disease. Clin Otolaryngol Allied Sci 1990; 15 (06) 545-548
    CrossrefPubMedGoogle Scholar
  • 4 Parnes LS, Riddell D. Irritative spontaneous nystagmus following intratympanic gentamicin for Menière's disease. Laryngoscope 1993; 103 (07) 745-749
    PubMedGoogle Scholar
  • 5 Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Ménière's disease: results of therapy. Am J Otol 1997; 18 (01) 52-57
    Google Scholar
  • 6 Corsten M, Marsan J, Schramm D, Robichaud J. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience. J Otolaryngol 1997; 26 (06) 361-364
    PubMedGoogle Scholar
  • 7 Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 1997; 107 (01) 49-55
    CrossrefPubMedGoogle Scholar
  • 8 Kaplan DM, Nedzelski JM, Al-Abidi A, Chen JM, Shipp DB. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease. J Otolaryngol 2002; 31 (02) 106-111
    CrossrefPubMedGoogle Scholar
  • 9 Harner SG, Kasperbauer JL, Facer GW, Beatty CW. Transtympanic gentamicin for Meniere's syndrome. Laryngoscope 1998; 108 (10) 1446-1449
    CrossrefPubMedGoogle Scholar
  • 10 Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999; 20 (02) 209-219
    Google Scholar
  • 11 Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 1999; 20 (03) 357-363
    Google Scholar
  • 12 Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease. Otol Neurotol 2003; 24 (05) 800-806
    CrossrefPubMedGoogle Scholar
  • 13 Flanagan S, Mukherjee P, Tonkin J. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease. J Laryngol Otol 2006; 120 (02) 98-102
    CrossrefPubMedGoogle Scholar
  • 14 De Beer L, Stokroos R, Kingma H. Intratympanic gentamicin therapy for intractable Ménière's disease. Acta Otolaryngol 2007; 127 (06) 605-612
    CrossrefPubMedGoogle Scholar
  • 15 Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012; 146 (03) 430-437
    CrossrefPubMedGoogle Scholar
  • 16 Adamonis J, Stanton SG, Cashman MZ, Mattan K, Nedzelski JM, Chen JM. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report. Am J Otol 2000; 21 (04) 534-542
    Google Scholar
  • 17 Büki B, Platz M, Haslwanter T, Jünger H, Avan P. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection. Audiol Neurootol 2011; 16 (01) 49-54
    CrossrefPubMedGoogle Scholar
  • 18 Perez N, Boleas MS, Martin E. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease. Audiol Neurootol 2005; 10 (02) 69-78
    CrossrefPubMedGoogle Scholar
  • 19 Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function. Otolaryngol Head Neck Surg 2005; 133 (06) 929-935
    CrossrefPubMedGoogle Scholar
  • 20 Yetiser S, Kertmen M. Intratympanic gentamicin in Menière's disease: the impact on tinnitus. Int J Audiol 2002; 41 (06) 363-370
    CrossrefPubMedGoogle Scholar
  • 21 Allison RS, Eizenman M, Tomlinson RD, Nedzelski J, Sharpe JA. Vestibulo-ocular reflex deficits to rapid head turns following intratympanic gentamicin instillation. J Vestib Res 1997; 7 (05) 369-380
    CrossrefPubMedGoogle Scholar
  • 22 Marques P, Manrique-Huarte R, Perez-Fernandez N. Single intratympanic gentamicin injection in Ménière's disease: VOR change and prognostic usefulness. Laryngoscope 2015; 125 (08) 1915-1920
    CrossrefPubMedGoogle Scholar
  • 23 Cerchiai N, Navari E, Dallan I, Sellari-Franceschini S, Casani AP. Assessment of vestibulo-oculomotor reflex in Ménière's disease: defining an instrumental profile. Otol Neurotol 2016; 37 (04) 380-384
    CrossrefPubMedGoogle Scholar
  • 24 Tribukait A, Bergenius J, Brantberg K. Subjective visual horizontal during follow-up after unilateral vestibular deafferentation with gentamicin. Acta Otolaryngol 1998; 118 (04) 479-487
    CrossrefPubMedGoogle Scholar
  • 25 Takai Y, Murofushi T, Ushio M, Iwasaki S. Recovery of subjective visual horizontal after unilateral vestibular deafferentation by intratympanic instillation of gentamicin. J Vestib Res 2006; 16 (1-2): 69-73
    PubMedGoogle Scholar
  • 26 Picciotti PM, Fiorita A, Di Nardo W, Quaranta N, Paludetti G, Maurizi M. VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease. J Vestib Res 2005; 15 (03) 161-168
    PubMedGoogle Scholar
  • 27 Gode S, Celebisoy N, Akyuz A. , et al. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome. Am J Otolaryngol 2011; 32 (05) 412-416
    CrossrefPubMedGoogle Scholar
  • 28 Guinand N, Pijnenburg M, Janssen M, Kingma H. Visual acuity while walking and oscillopsia severity in healthy subjects and patients with unilateral and bilateral vestibular function loss. Arch Otolaryngol Head Neck Surg 2012; 138 (03) 301-306
    CrossrefPubMedGoogle Scholar
  • 29 Pyykkö I, Eklund S, Ishizaki H, Aalto H. Postural compensation after intratympanic gentamicin treatment of Menière's disease. J Vestib Res 1999; 9 (01) 19-26
    PubMedGoogle Scholar
  • 30 Perez N, Rama-Lopez J. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease. J Vestib Res 2005; 15 (01) 49-58
    PubMedGoogle Scholar
  • 31 Bertino G, Durso D, Manfrin M, Casati L, Mira E. Intratympanic gentamicin in monolateral Meniere's disease: our experience. Eur Arch Otorhinolaryngol 2006; 263 (03) 271-275
    CrossrefPubMedGoogle Scholar
  • 32 Toth AA, Parnes LS. Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens. J Otolaryngol 1995; 24 (06) 340-344
    PubMedGoogle Scholar
  • 33 Lin FR, Migliaccio AA, Haslwanter T, Minor LB, Carey JP. Angular vestibulo-ocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Meniere's disease. Ann Otol Rhinol Laryngol 2005; 114 (10) 777-785
    CrossrefPubMedGoogle Scholar